Practice

European Commission Approves Pfizer's Pegfilgrastim Biosimilar

November 23, 2020

Tony Hagen

Article

Pfizer aims to begin marketing Nyvepria in the European Union in the first quarter of 2021.

Opinion: Embrace the Era of Next-Generation Biologics

November 21, 2020

Bincy P. Abraham, MD

Article

Bincy P. Abraham, MD, explains that even when payers allow coverage for biosimilars, providers may still be hesitant to use them.

Not So Different: Kathy Oubre on the Benefits of Using Biosimilars in a Community Oncology Practice

November 15, 2020

Podcast

Kathy Oubre, MS, chief operating officer at the Pontchartrain Cancer Center in Louisiana, discusses the value of biosimilars.

ACR: UHC's New Co-pay Policy Is "Disastrous" for Patients

October 29, 2020

Tony Hagen

Article

The American College of Rheumatology (ACR) has joined with other provider groups in opposing a UnitedHealthcare (UHC) plan that could increase patient out-of-pocket costs.

Safety, Efficacy, and Savings Result From Study of Nonmedical Switching

October 26, 2020

Tony Hagen

Article

A study of mandatory switching for patients with rheumatologic conditions led to savings without effect on safety or efficacy.

Europeans Devise Checklist for Promoting Biosimilar Use

October 24, 2020

Deana Ferreri, PhD

Article

European investigators have derived a set of core principals for developing higher utilization of biosimilars.

Need for Biosimilar Cooperation Among Hospitals, Infusion Centers, and Payers Is Identified

October 22, 2020

Skylar Jeremias

Article

Overcoming biosimilar uptake barriers will take collaboration and policy change by hospitals, infusion clinics, and health plans, presenters said at the Academy of Managed Care Pharmacy Nexus 2020 Virtual conference.

Report: Specialty Drug Assessment Highlights Biosimilar Progress

October 12, 2020

Skylar Jeremias

Article

Sometimes the reference product exhibits pricing resistance against the competitive effect of biosimilars, according to a Pharmaceutical Strategies Group report.

ASCO Survey Measures COVID-19 Effect on Cancer Treatment

October 5, 2020

Tony Hagen

Article

During the coronavirus disease 2019 (COVID-19) pandemic, patients are more likely to have delayed cancer screenings rather than their doctors and clinics.

Patt: Payers Could Save More With Biosimilars

September 25, 2020

Tony Hagen

Article

Debra Patt, MD, PhD, MBA, discusses issues affecting biosimilar uptake at the Patient-Centered Oncology Care® 2020 virtual conference.

x